Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder.
Saved in:
| Title: | Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder. |
|---|---|
| Authors: | Seetasith A; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA, Falls Church, VA 22042, USA., Greene M; Health Economics and Outcomes Research, Otsuka Pharmaceutical Development And Commercialization, Inc., Princeton, NJ 08540, USA., Hartry A; Health Economics and Outcomes Research, Lundbeck, Deerfield, IL 60015, USA., Burudpakdee C; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA, Falls Church, VA 22042, USA. |
| Source: | ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2019 Dec 04; Vol. 11, pp. 741-755. Date of Electronic Publication: 2019 Dec 04 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101560564 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6981 (Print) Linking ISSN: 11786981 NLM ISO Abbreviation: Clinicoecon Outcomes Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
